Vice Provost and Dean of Research
Showing 2,001-2,050 of 2,458 Results
-
Christopher Sharp, MD
Clinical Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsClinical Informatics
Clinical Education
Teaching Physical Examination
Quality Improvement
Preventive Medicine -
Carla Shatz
Sapp Family Provostial Professor and Professor of Biology and of Neurobiology
Current Research and Scholarly InterestsThe goal of research in the Shatz Laboratory is to discover how brain circuits are tuned up by experience during critical periods of development both before and after birth by elucidating cellular and molecular mechanisms that transform early fetal and neonatal brain circuits into mature connections. To discover mechanistic underpinnings of circuit tuning, the lab has conducted functional screens for genes regulated by neural activity and studied their function for vision, learning and memory.
-
Gary M. Shaw
Rosemarie Hess Professor and Professor (Research), by courtesy, of Epidemiology and Population Health and of Obstetrics and Gynecology (Maternal Fetal Medicine)
Current Research and Scholarly InterestsPrimary research interests include 1) epidemiology of birth defects, 2) gene-environment approaches to perinatal outcomes, and 3) nutrition and reproductive outcomes.
-
Kevin Shea
Chambers-Okamura Endowed Professor of Pediatric Orthopaedics
BioKevin G. Shea, MD is at Stanford University. He grew up in Montana and California, graduated from the University of Notre Dame, UCLA School of Medicine, and completed his orthopaedic residency at the University of Utah. His advanced training includes pediatric orthopaedics at Rady Children’s Hospital in San Diego, AO Fellowship in Bern Switzerland with Dr. Ganz (Hip), Dr. Diego Fernandez (Trauma), and Dr. Hans Staubli (sports), Ilizarov Training in Lecco, Italy. He has done the AOSSM South American Traveling Sports Medicine Fellowship, and education in Russia and former Soviet Bloc countries. Most of his early career was in Boise, Idaho. Dr. Shea is a founding member of the PRISM Society (Pediatric Research in Sports Medicine) and the ROCK (Research in Osteochondritis Dissecans of the Knee) Multi-center Study Group, and the SCORE (Sports Cohort Outcomes Research ) Multi-Center Registry for pediatric sports. He has authored more than 300 scientific papers and chapters. His clinic research interests include cartilage and ligament disorders, using pediatric cadaveric tissue and surgical 3D simulations to develop surgeries and improve outcomes for procedures that avoid damage to growth plates. He has years of experience with performance, quality improvement, value, and he worked extensively with the AAOS Quality/Clinical Practice Guideline Committees. He is one of the POSNA members to launch the POSNA Safe Surgery Program. He is a national quality leader in health care with interests in patient safety, risk reduction, and improving value in health care with clinician integration into supply chain. He is an avid cyclist, trail runner, hiker, and spends as much time outside as possible, with his partner Lonnie and their children Beck and Cooper.
-
Jeanne Shen
Associate Professor of Pathology
Current Research and Scholarly InterestsGastrointestinal and pancreatobiliary pathology, with major emphasis on GI and pancreatic neoplasia, inflammatory bowel disease, biodesign innovation, and the application of machine learning to digital pathology.
-
Kang Shen
Vincent V.C. Woo Director, Wu Tsai Neurosciences Institute, Frank Lee and Carol Hall Professor and Professor of Biology and of Pathology
Current Research and Scholarly InterestsThe connectivity of a neuron (its unique constellation of synaptic inputs and outputs) is essential for its function. Neuronal connections are made with exquisite accuracy between specific types of neurons. How each neuron finds its synaptic partners has been a central question in developmental neurobiology. We utilize the relatively simple nervous system of nematode C. elegans, to search for molecules that can specify synaptic connections and understand the molecular mechanisms of synaptic as
-
Zhi-Xun Shen
Paul Pigott Professor of Physical Sciences, Professor of Applied Physics, of Physics and Senior Fellow at the Precourt Institute for Energy
Current Research and Scholarly InterestsDr. Shen's main research interest lies in the area of condensed matter and materials physics, as well as the applications of materials and devices. He develops photon based innovative instrumentation and advanced experimental techniques, ranging from angle-resolved photoemission to microwave imaging, soft x-ray scattering and time domain spectroscopy and scattering. He has created a body of literature that advanced our understanding of quantum materials, including superconductors, semiconductors, novel magnets, topological insulators, novel carbon and electron emitters. He is best known for his discoveries of the momentum structure of anisotropic d-wave pairing gap and anomalous normal state pseudogap in high temperature superconductors. He has further leveraged the advanced characterization tool to make better materials through thin film and interface engineering.
-
Krishna Shenoy
Member, Bio-X
Current Research and Scholarly InterestsWe conduct neuroscience, neuroengineering and translational research to better understand how the brain controls movement, and to design medical systems to assist people with paralysis. These are referred to as brain-machine interfaces (BMIs), brain-computer interfaces (BCIs) and intra-cortical neural prostheses. We conduct this research as part of our Neural Prosthetic Systems Lab (NPSL) and our Neural Prosthetics Translational Lab (NPTL), which I co-direct with Prof. Jaimie Henderson, M.D.
-
Sheri D. Sheppard
Richard W. Weiland Professor in the School of Engineering, Emerita
BioSheri Sheppard teaches both undergraduate and graduate design-related classes, and conducts research on fracture mechanics and applied finite element analysis, and on how people become engineers. From 1999-2008 she served as a Senior Scholar at the Carnegie Foundation for the Advancement of Teaching, leading the Foundation’s engineering study. In addition to publishing technical papers, reports, and textbooks, she has led or co-led several large, multi-institutional projects to build new educational research programs and related resources, such as the Center for the Advancement of Engineering Education (CAEE), The National Center for Engineering Pathways to Innovation (Epicenter), and a program on summer research experiences for high school teachers. Her industry experience includes engineering positions at Detroit's "Big Three” — Ford Motor Company, General Motors Corporation, and Chrysler Corporation. She earned her bachelors degree from the University of Wisconsin, and her PhD at the University of Michigan. At Stanford she has served a chair of the faculty senate, as associate vice provost for graduate education, and is the longtime faculty founder of and adviser to the graduate student group MEwomen. Her work has been recognized with numerous honors and awards, including the Walter J. Gores Award, Stanford University's highest award for excellence in teaching and the Chester F. Carlson and Ralph Coats Roe Awards of the American Society for Engineering Education in recognition of distinguished accomplishment in engineering education, and for outstanding teaching and notable contributions to the mechanical engineering profession.
-
Gavin Sherlock
Professor of Genetics
On Leave from 03/02/2026 To 03/31/2026Current Research and Scholarly InterestsEvolution and the adaptive landscape using yeast as a model; Defining yeast transcriptomes; chromosomal evolution in hybrid yeast species
-
Seth Lawrence Sherman, MD
Associate Professor of Orthopaedic Surgery
Current Research and Scholarly InterestsMy research focuses on ways to augment tissue healing, improve human performance, and prevent musculoskeletal injuries. Approaching these challenges through parallel basic science and clinical pathways, our team works from the “bedside to the bench and back to the bedside”, identifying areas of clinical need to deliver evidence-based solutions for patients.
We collaborates with orthopaedic surgeons, non-surgical physicians, and researchers within bioengineering, human performance, and musculoskeletal imaging across the Stanford campus. The team is developing novel methods to accurately record human movement (including wearable technology, phone-based systems), rapid MRI imaging protocols, and exploring the use of biomarkers to track injury and recovery. This research builds on my earlier work, which utilized portable, inexpensive software for Microsoft Kinect to detect knee injury risk in youth athletes performing a drop vertical jump test. The team’s multifaceted goal is: 1) develop innovative methods to screen for injury risk (i.e. youth athlete non-contact ACL), 2) create targeted intervention programs to reduce risk, 3) enhance athletic performance; and 4) improve accuracy of return to play testing following injury/surgery (i.e. clinical evaluation, biomarkers, functional tests, imaging analysis for healing).
In the laboratory,our team investigates cellular and molecular deficiencies in tissue types including tendon, ligament, articular cartilage, and meniscus. By understanding aberrant pathways leading to tissue injury, they can identify innovative therapeutic targets for intervention. In collaboration with the Genetic Engineering and Synthetic Biology laboratories, Dr. Sherman’s research has explored the role of orthobiologic agents such as platelet rich plasma (PRP) and bone marrow aspirate concentrate (BMAC) for tissue healing in patella tendinopathy (the breakdown of collagen in a tendon). Our lab is also investigating the use of CBD for musculoskeletal applications as an alternative to commonly used local anesthetics and cortisone derivatives. In my earlier work, we researched the cellular toxicity of such applications.
In addition to basic science research, I have helped to build a Sports Medicine clinical research team that includes several full-time clinical research coordinators, residents, fellows, and students. The team collects prospective outcomes on their patients using a novel data collection platform called Patient IQ. The group is part of the JUPITER study which is the largest, multicenter study ever assembled in patellofemoral instability. They are additionally planning to enroll in FDA-approved clinical studies investigating pioneering strategies for knee cartilage restoration, joint preservation, and orthobiologic injections for osteoarthritis. Recent clinical publications explore outcomes in meniscus preservation and transplantation, medial patellofemoral ligament reconstruction, osteochondral allograft and matrix-induced autologous chondrocyte implantation (MACI), and surgical augmentation using PRP/BMAC. The clinical research team actively reports results of non-surgical and surgical interventions to continue to introduce new knowledge to the field, with the goal of improved patient outcome. -
Aditi Sheshadri
Assistant Professor of Earth System Science and Center Fellow, by courtesy, at the Woods Institute for the Environment
BioI joined Stanford's Earth System Science department as an assistant professor 2018. Prior to this, I was a a Junior Fellow of the Simons Foundation in New York, and a postdoctoral research scientist at Columbia University’s Department of Applied Physics and Applied Math and the Lamont-Doherty Earth Observatory. I got my Ph.D. in Atmospheric Science at MIT's Department of Earth, Atmospheric, and Planetary Sciences, in the Program for Atmospheres, Oceans, and Climate, where I worked with R. Alan Plumb. I’m broadly interested in atmosphere and ocean dynamics, climate variability, and general circulation.
I'm particularly interested in fundamental questions in atmospheric dynamics, which I address using a combination of theory, observations, and both idealized and comprehensive numerical experiments. Current areas of focus include the dynamics, variability, and change of the mid-latitude jets and storm tracks, the stratospheric polar vortex, and atmospheric gravity waves. -
Vipul Sheth, MD, PhD
Assistant Professor of Radiology (Body MRI)
Current Research and Scholarly InterestsMy interests are in the development and translation of imaging technologies geared toward disease detection and characterization to better guide prognosis, treatment, and improve outcomes. I’m interested in supporting the development of MRI guided focal therapy methods which can personalize treatment and reduce the risk of morbidity from more invasive therapies.
Clinical Interests
- MRI for diagnosis of pelvic floor disorders
- MRI and PET/MRI to pelvic malignancies and lymph node staging.
- Whole Body MRI
- MRI guided procedures including biopsies, cryoablation, and high intensity focused ultrasound.
Translational Research Interests
- Development and translation of magnetic resonance imaging technologies to improve both diagnostics and therapeutics
- Molecular imaging and characterization of the tumor microenvironment
- Ultrashort echo time MRI applications in the body
- Developing synergistic MRI methods to complement PET in potential applications for PET/MRI -
Gi-Wook Shin
William J. Perry Professor, Senior Fellow at the Freeman Spogli Institute for International Studies and Professor, by courtesy, of East Asian Languages and Cultures
Current Research and Scholarly InterestsKorean democratization; Korean nationalism; U.S.-Korea relations; North Korean politics; reconciliation and cooperation in Northeast Asia; global talent; multiculturalism; inter-Korean relations
-
Josh Shiode
Managing Director, KIPAC
BioJosh Shiode is Managing Director of the Kavli Institute for Particle Astrophysics and Cosmology (KIPAC), a joint institute of Stanford University and the SLAC National Laboratory. Prior to joining KIPAC, Josh served as Senior Advisor and Chief of Staff in the U.S. Department of Energy Office of Science, under the leadership of then Director Asmeret Asefaw Berhe. Josh received his PhD in astrophysics from UC Berkeley in 2013, and subsequently worked in a variety of science and technology policy roles in Washington, DC, including with the American Association for the Advancement of Science and the Pacific Northwest National Laboratory.
-
Judith Shizuru
Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Current Research and Scholarly InterestsTransplantation of defined populations of allogeneic hematopoietic cells. Specifically, the way in which hematopoietic cell grafts alter antigen specific immune responses to allo-, auto- and viral antigens. The cellular and molecular basis of resistance to engraftment of allogeneic hematopoietic stem cells.
-
Linda M. Dairiki Shortliffe
Stanley McCormick Memorial Professor in the School of Medicine, Emerita
Current Research and Scholarly InterestsThe timing for intervention in obstruction in the infant and child is poorly understood.Our group has been interested in trying to define the risks that may be involved in obstructive and infectious uropathies and discovering early signs of damage to the urinary tract and kidney. We have explored ways of imaging the urinary tract using nonionizing radiation (US, MRI). We have studied the relationships of sex steroid hormones, pregnancy, reflux, urinary tract infection and urinary tract function.
-
Joseph Shrager
Professor of Cardiothoracic Surgery
Current Research and Scholarly InterestsIn clinical research, Dr. Shrager studies outcomes in a variety of areas within Thoracic Surgery including: parenchyma-sparing operations and minimally invasive resections for lung cancer, transcervical thymectomy for myasthenia gravis, diaphragm plication, and surgical treatment of emphysema.
Dr. Shrager's lab is focused on the impact of disease states upon the diaphragm. His group published the seminal paper (NEJM) describing diaphragm atrophy assoc'd with mechanical ventilation. -
Surbhi Sidana, MD
Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
BioDr. Surbhi Sidana is an Associate Professor of Medicine at Stanford University and specializes in the treatment of multiple myeloma and related disorders. She leads the Myeloma CAR-T/Immunotherapy program at Stanford.
Dr Sidana grew up in Delhi, India. She completed her Internal Medicine Residency at Cleveland Clinic in Cleveland, Ohio, followed by Hematology/Oncology fellowship at Mayo Clinic in Rochester, MN. Following this, she completed an Advanced Hematology Fellowship in Myeloma, Amyloidosis and Related Disorders at Mayo Clinic in Rochester, MN before joining Stanford University as a faculty member in 2019, where she has led the development of the myeloma CAR-T and bispecific antibody program.
Dr Sidana has an active, broad research portfolio that includes clinical trials of novel therapies in myeloma and related disorders, translational research, epidemiologic and patient reported outcome studies. She has a special focus on research with immunotherapies such as CAR-T cell therapy and bispecific antibodies. She has published over 100 research manuscripts. Dr Sidana is the Leader of the Myeloma Disease Focused Group and the Associate Director for Clinical Research in the BMT and Cell Therapy Division at Stanford University. She also co-leads a multi-institutional collaboration on real world outcomes with immunotherapies in myeloma.
Dr Sidana is actively involved in and holds leadership positions in national and international professional societies. She is the Chair of the American Society of Hematology Committee on Communications, and Co-Chairs the Quality-of-Life Committee of the International Myeloma Working Group. She is a member of the SWOG Myeloma Committee and BMT CTN Myeloma Intergroup, where she works with colleagues across the nation to develop innovative and practice changing trials focused on multiple myeloma . -
Constantine Sideris
Associate Professor of Electrical Engineering
BioConstantine Sideris is an Associate Professor of Electrical Engineering at Stanford University. Previously, he was an Assistant Professor at the University of Southern California from 2018 to 2025 and an Associate Professor from 2025 to 2026. He received the B.S., M.S., and Ph.D. degrees with honors from the California Institute of Technology in 2010, 2011, and 2017 respectively. He was a visiting scholar at UC Berkeley’s Wireless Research Center from 2013 to 2014. He was a postdoctoral fellow in the departments of Electrical Engineering and Computing and Mathematical Sciences at Caltech from January 2017 to August 2018.
He was the recipient of an ONR YIP award in 2023, an NSF CAREER award in 2021, an AFOSR YIP award in 2020, an AFOSR DURIP award in 2021, the Caltech Leadership Award in 2017, and an NSF graduate research fellowship in 2010. His research is highly interdisciplinary and bridges the fields of bioengineering, medicine, applied mathematics and computation with electrical engineering and physics.
His research interests include analog/RF integrated circuits, photonic integrated circuits, and computational electromagnetics for biomedical and biosensing applications and wireless communications. His current interests in biomedical devices include portable Point-of-Care in-vitro biosensors, wearable devices for real-time monitoring and analysis of biological signals, ingestible “smart” pills, and implantable devices. His current interests in computational electromagnetics include developing fast algorithms for simulating RF and nanophotonic devices and coupling them with efficient optimization algorithms to achieve the automated design of new, high-performance electromagnetic devices. -
Arend Sidow
Professor of Pathology and of Genetics
Current Research and Scholarly InterestsWe have a highly collaborative research program in the evolutionary genomics of cancer. We apply well-established principles of phylogenetics to cancer evolution on the basis of whole genome sequencing and functional genomics data of multiple tumor samples from the same patient. Introductions to our work and the concepts we apply are best found in the Newburger et al paper in Genome Research and the Sidow and Spies review in TIGS.
More information can be found here: http://www.sidowlab.org -
Julia Fridman Simard
Associate Professor of Epidemiology and Population Health, of Medicine (Immunology & Rheumatology) and, by courtesy, of Obstetrics and Gynecology (Maternal Fetal Medicine)
BioJulia Fridman Simard, ScD, is an Associate Professor of Epidemiology & Population Health, and of Medicine in Immunology and Rheumatology and Obstetrics and, by courtesy, Gynecology in Maternal Fetal Medicine at Stanford University School of Medicine.
Dr. Simard earned her Masters and Doctorate of Science in Epidemiology degrees at the Harvard School of Public Health. During that time she trained with investigators at the Section of Clinical Sciences, Division of Rheumatology, Immunology, and Allergy at Brigham and Women’s Hospital and the Cardiovascular Epidemiology Research Unit at Beth Israel Deaconess Medical Center. In 2008, Dr. Simard relocated to Sweden to begin a Postdoctoral Fellowship in Clinical Epidemiology at the Karolinska Institutet in Stockholm. She became an Assistant Professor in their Clinical Epidemiology Unit in 2011, and was later honored with a Karolinska Institutet Teaching Award. Leveraging the population-based registers of Sweden, Dr. Simard initiated a national register linkage study to examine the utility of registers in Systemic Lupus Erythematosus (SLE) research and develop an extensive data repository for future epidemiologic investigations.
While maintaining a close collaboration with the Karolinska Institutet, she joined Stanford’s Epidemiology faculty in 2013. Dr. Simard studies outcomes such as malignancy, stroke, infection, and mortality, in patients with systemic autoimmune rheumatic diseases with a focus on systemic lupus erythematosus. Recently her primary research focus has shifted to the intersection between reproductive epidemiology and rheumatic disease fueled by a K01 career development award from the NIH (NIAMS) to study maternal and fetal outcomes in systemic lupus pregnancy. This led to collaborations with colleagues at Stanford, throughout the US, and abroad, and a series of projects focused on the diagnosis of preeclampsia and associated risks in pregnant women with systemic lupus. Dr. Simard was awarded a Peter Joseph Pappas Research Grant from the Preeclampsia Foundation for her lab's work examining preeclampsia risk in high-risk populations, and a McCormick Faculty Award from Stanford Medicine to take important steps towards disentangling preeclampsia from lupus nephritis. Dr. Simard is leading an international study of hydroxychloroquine in lupus pregnancy leveraging mixed methods in partnership with qualitative researchers, patients, clinicians, and epidemiologists in Sweden, Canada, and in the United States.
In addition to these issues of misclassification in reproductive rheumatology questions, Dr. Simard's lab is also interested in how misclassification, missed opportunities, and misdiagnosis contribute to disparities in complex conditions such as systemic lupus. In addition to methodologic issues around misclassification and bias and the largely clinical epidemiology focus of her work, Dr. Simard's work examines social determinants of health and health disparities. Dr. Simard was recently awarded an R01 from NIH (NIAID) to study the role of cognitive errors in clinical decision making for female-predominant diseases including lupus and multiple sclerosis. This work evaluates this bias in multiple clinical specialties, including rheumatology, neurology, and primary care, and uses mixed methods. -
Laura Simons
Professor of Anesthesiology, Perioperative and Pain Medicine (Pediatric)
Current Research and Scholarly InterestsI am a Professor in the Department of Anesthesiology, Perioperative, and Pain Medicine at Stanford University School of Medicine and a clinical psychologist who evaluates and treats youth presenting with chronic pain in the Pediatric Pain Management Clinic (PPMC) at Stanford Children’s Health. My program of research aims to utilize a pain neuroscience psychology approach to gain a mechanistic understanding of cognitive and affective processes in pediatric pain, perform rigorous patient-oriented research that translates targeted assessment into mechanistically informed treatment approaches for optimal clinical care and leverage the ubiquity of digital health to enhance patient access and reach. Central to these goals are projects targeting adolescence and youth adults with chronic pain that encompass defining brain signatures of threat interpretation, evaluating the efficacy of graded exposure (NCT03699007), deriving a biosignature of improvement vs. persistence of pain and disability (NCT04285112), and evaluating the impact of virtual reality on pain rehabilitation (NCT04636177). These studies along with additional work examining the journey of pain care for youth with pain and their parents form a comprehensive research portfolio in the realm of understanding and treating chronic pain in young people. My long-term career goal is to lead a robust research program focusing on alleviating the suffering of youth and emerging adults with chronic pain.
-
Robert Sinclair
Charles M. Pigott Professor in the School of Engineering
BioUsing high-resolution transmission electron microscopy, Sinclair studies microelectronic, magnetic thin film microstructure and nanomaterials.
-
Kuldev Singh, MD, MPH
Professor of Ophthalmology
Current Research and Scholarly InterestsGlaucoma, clinical epidemiology
-
Upinder Singh
Stanford Medicine Professor of Infectious Disease and Professor of Medicine (Infectious Diseases & Geographic Medicine), Emerita
Current Research and Scholarly InterestsOur lab elucidates the molecular basis of pathogenesis of the protozoan parasite Entamoeba histolytica. We use genetic and genomic approaches to identify novel virulence determinants and to characterize the global epidemiology of the parasite.
-
Sidhartha Sinha
Assistant Professor of Medicine (Gastroenterology and Hepatology)
Current Research and Scholarly InterestsThere are two primary and overlapping emphases of my research, both of which are driven and united by needs-based innovation and translational potential:
(1) Understanding the microenvironment of the inflamed versus normal gut in order to identify better therapeutic targets for people with immune-¬mediated GI disorders. Here, our investigations include understanding the influence and interactions of pharmacologic and dietary interventions on gut microbiome/metabolomic changes and the host immune response. In the context of providing patients with new understanding and solutions for their disease, I have led and advised on the design of both pilot and large clinical trials (including new FDA approved therapies) for anti-inflammatory therapies;
(2) Applying novel approaches and technologies (including natural language processing, computer vision, and reinforcement learning) to identify and address unmet clinical needs. In this area we have ongoing and published efforts in my lab to validate and develop solutions to pressing clinical needs. We have developed/led new drug delivery technologies with a multidisciplinary team that have shown strong potential in ongoing human IBD clinical trials. My lab has utilized both supervised and unsupervised approaches to analyze social media discourse and unstructured data sets for identifying patient needs that are rarely addressed in clinical settings. We have gained insights into patient perceptions around preventative health interventions, such as health screening and diet, including the dearth of evidence-based dietary recommendations to treat IBD (despite strong patient desire for solutions in this domain). -
Tammy Lisa Sirich
Assistant Professor of Medicine (Nephrology)
Current Research and Scholarly InterestsI conduct translational research focused on uremia and dialysis. I use mass spectrometry to conduct studies testing ways to reduce levels of solutes and examining the contribution of uremic solutes to illness.
-
Stephen Skirboll
Associate Professor of Neurosurgery
Current Research and Scholarly InterestsMy research focuses on screening strategies to identify and characterize cancer stem cells (CSCs) in human gliomas. We are pursuing this in several ways: 1) a novel colony-forming antibody live cell array to identify distinct CSC surface phenotypes, 2) RNAi screens to identify kinases critical for CSC tumorigenicity, 3) high throughput small molecule and chemical screens to identify compounds that selectively kill or target CSCs, and 4) identifying CSCs using the tumor specific EGFRvIII
-
Jan Skotheim
Professor of Biology and, by courtesy, of Chemical and Systems Biology
Current Research and Scholarly InterestsMy overarching goal is to understand how cell growth triggers cell division. Linking growth to division is important because it allows cells to maintain specific size range to best perform their physiological functions. For example, red blood cells must be small enough to flow through small capillaries, whereas macrophages must be large enough to engulf pathogens. In addition to being important for normal cell and tissue physiology, the link between growth and division is misregulated in cancer.
